1. Home
  2. DIT vs DBVT Comparison

DIT vs DBVT Comparison

Compare DIT & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMCON Distributing Company

DIT

AMCON Distributing Company

N/A

Current Price

$106.00

Market Cap

74.2M

ML Signal

N/A

DBVT

DBV Technologies S.A.

HOLD

Current Price

$16.74

Market Cap

769.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DIT
DBVT
Founded
1981
2002
Country
United States
France
Employees
N/A
N/A
Industry
Food Distributors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.2M
769.4M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
DIT
DBVT
Price
$106.00
$16.74
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$31.75
AVG Volume (30 Days)
811.0
654.6K
Earning Date
01-16-2026
10-28-2025
Dividend Yield
0.93%
N/A
EPS Growth
N/A
N/A
EPS
0.92
N/A
Revenue
$2,254,788,287.00
$5,502,000.00
Revenue This Year
N/A
$1,768.71
Revenue Next Year
N/A
$1,028.88
P/E Ratio
$117.27
N/A
Revenue Growth
5.29
N/A
52 Week Low
$94.92
$3.30
52 Week High
$156.99
$26.19

Technical Indicators

Market Signals
Indicator
DIT
DBVT
Relative Strength Index (RSI) 38.71 45.59
Support Level $103.69 $18.78
Resistance Level $110.80 $19.62
Average True Range (ATR) 2.19 1.47
MACD -0.61 -0.49
Stochastic Oscillator 20.56 3.72

Price Performance

Historical Comparison
DIT
DBVT

About DIT AMCON Distributing Company

Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: